The therapeutic potential of small molecule TACE inhibitors

Expert Opinion on Investigational Drugs

Volumn 8, Issue 4, 1999, Pages 383-392

  Nelson, F C ^a   Zask, A ^a  

^a PFIZER INC   (United States)

Author keywords

A disintegrin and metalloproteinase domain; Crohn's disease; Enzyme inhibitor; Matrix metalloproteinase; Rheumatoid arthritis; Sheddase; TNF converting enzyme; Tumour necrosis factor (TNF )

Indexed keywords

DEXAMETHASONE; DIPEPTIDYL CARBOXYPEPTIDASE; ETANERCEPT; GCS 27023; GW 3333; HYBRID PROTEIN; INFLIXIMAB; METALLOPROTEINASE; METALLOPROTEINASE INHIBITOR; METHOTREXATE; PENTOXIFYLLINE; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; TUMOR NECROSIS FACTOR CONVERTING ENZYME; TUMOR NECROSIS FACTOR CONVERTING ENZYME INHIBITOR; UNCLASSIFIED DRUG;

CROHN DISEASE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME INHIBITION; HUMAN; NONHUMAN; REVIEW; RHEUMATOID ARTHRITIS;

EID: 0032961923     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.8.4.383     Document Type: Review

References (43)